Shares of Max Healthcare Institute Limited declined by 1.13% to Rs 1,124.80 in Friday's session, amid high volume. The stock witnessed heavy trading activity.
Financial Highlights
Max Healthcare Institute's financial performance shows consistent growth in both quarterly and annual results. Here's a summary of key financial data:
Consolidated Quarterly Performance:
Heading | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
---|---|---|---|---|---|
Revenue | Rs 1,542.95 Crore | Rs 1,707.46 Crore | Rs 1,868.31 Crore | Rs 1,909.74 Crore | Rs 2,027.57 Crore |
Net Profit | Rs 236.27 Crore | Rs 281.81 Crore | Rs 238.80 Crore | Rs 319.00 Crore | Rs 307.97 Crore |
EPS | 2.43 | 2.90 | 2.46 | 3.28 | 3.17 |
Consolidated Yearly Performance:
Heading | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Revenue | Rs 2,504.67 Crore | Rs 3,931.46 Crore | Rs 4,562.60 Crore | Rs 5,406.02 Crore | Rs 7,028.46 Crore |
Net Profit | -114.50 Crore | Rs 605.05 Crore | Rs 1,103.51 Crore | Rs 1,057.64 Crore | Rs 1,075.88 Crore |
EPS | -1.59 | 6.25 | 11.38 | 10.89 | 11.07 |
BVPS | 58.37 | 64.79 | 76.31 | 86.51 | 96.50 |
ROE | -2.43 | 9.63 | 14.89 | 12.57 | 11.46 |
Debt to Equity | 0.16 | 0.12 | 0.08 | 0.14 | 0.27 |
Consolidated Yearly Income Statement:
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
---|---|---|---|---|---|
Sales | Rs 7,028 Crore | Rs 5,406 Crore | Rs 4,562 Crore | Rs 3,931 Crore | Rs 2,504 Crore |
Other Income | Rs 155 Crore | Rs 178 Crore | Rs 139 Crore | Rs 127 Crore | Rs 114 Crore |
Total Income | Rs 7,184 Crore | Rs 5,584 Crore | Rs 4,701 Crore | Rs 4,058 Crore | Rs 2,619 Crore |
Total Expenditure | Rs 5,612 Crore | Rs 4,158 Crore | Rs 3,554 Crore | Rs 3,219 Crore | Rs 2,508 Crore |
EBIT | Rs 1,571 Crore | Rs 1,425 Crore | Rs 1,147 Crore | Rs 839 Crore | Rs 110 Crore |
Interest | Rs 165 Crore | Rs 59 Crore | Rs 83 Crore | Rs 100 Crore | Rs 179 Crore |
Tax | Rs 330 Crore | Rs 307 Crore | Rs -39 Crore | Rs 133 Crore | Rs 45 Crore |
Net Profit | Rs 1,075 Crore | Rs 1,057 Crore | Rs 1,103 Crore | Rs 605 Crore | Rs -114 Crore |
Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | |
---|---|---|---|---|---|
Sales | Rs 2,027 Crore | Rs 1,909 Crore | Rs 1,868 Crore | Rs 1,707 Crore | Rs 1,542 Crore |
Other Income | Rs 36 Crore | Rs 46 Crore | Rs 33 Crore | Rs 40 Crore | Rs 34 Crore |
Total Income | Rs 2,064 Crore | Rs 1,956 Crore | Rs 1,901 Crore | Rs 1,748 Crore | Rs 1,577 Crore |
Total Expenditure | Rs 1,608 Crore | Rs 1,498 Crore | Rs 1,540 Crore | Rs 1,341 Crore | Rs 1,232 Crore |
EBIT | Rs 455 Crore | Rs 457 Crore | Rs 361 Crore | Rs 407 Crore | Rs 345 Crore |
Interest | Rs 54 Crore | Rs 55 Crore | Rs 52 Crore | Rs 33 Crore | Rs 23 Crore |
Tax | Rs 92 Crore | Rs 83 Crore | Rs 70 Crore | Rs 91 Crore | Rs 85 Crore |
Net Profit | Rs 307 Crore | Rs 319 Crore | Rs 238 Crore | Rs 281 Crore | Rs 236 Crore |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
---|---|---|---|---|---|
Share Capital | Rs 972 Crore | Rs 971 Crore | Rs 970 Crore | Rs 969 Crore | Rs 965 Crore |
Reserves & Surplus | Rs 8,408 Crore | Rs 7,368 Crore | Rs 6,397 Crore | Rs 5,290 Crore | Rs 4,646 Crore |
Current Liabilities | Rs 1,813 Crore | Rs 1,248 Crore | Rs 1,045 Crore | Rs 757 Crore | Rs 776 Crore |
Other Liabilities | Rs 4,019 Crore | Rs 2,410 Crore | Rs 1,688 Crore | Rs 2,171 Crore | Rs 2,155 Crore |
Total Liabilities | Rs 15,214 Crore | Rs 11,999 Crore | Rs 10,101 Crore | Rs 9,189 Crore | Rs 8,544 Crore |
Fixed Assets | Rs 8,922 Crore | Rs 6,384 Crore | Rs 4,836 Crore | Rs 4,714 Crore | Rs 4,108 Crore |
Current Assets | Rs 1,592 Crore | Rs 1,706 Crore | Rs 1,943 Crore | Rs 1,000 Crore | Rs 1,124 Crore |
Other Assets | Rs 4,699 Crore | Rs 3,909 Crore | Rs 3,322 Crore | Rs 3,474 Crore | Rs 3,311 Crore |
Total Assets | Rs 15,214 Crore | Rs 11,999 Crore | Rs 10,101 Crore | Rs 9,189 Crore | Rs 8,544 Crore |
Contingent Liabilities | Rs 1,374 Crore | Rs 1,169 Crore | Rs 326 Crore | Rs 515 Crore | Rs 388 Crore |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
---|---|---|---|---|---|
Operating Activities | Rs 1,459 Crore | Rs 1,121 Crore | Rs 1,209 Crore | Rs 748 Crore | Rs 117 Crore |
Investing Activities | Rs -1,631 Crore | Rs -1,285 Crore | Rs -1,187 Crore | Rs -771 Crore | Rs -73 Crore |
Financing Activities | Rs -163 Crore | Rs -263 Crore | Rs -288 Crore | Rs -294 Crore | Rs 191 Crore |
Others | Rs 17 Crore | Rs 32 Crore | Rs 0 Crore | Rs 0 Crore | Rs 279 Crore |
Net Cash Flow | Rs -318 Crore | Rs -394 Crore | Rs -266 Crore | Rs -317 Crore | Rs 515 Crore |
Ratio | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Basic EPS (Rs.) | 11.07 | 10.89 | 11.38 | 6.25 | -1.59 |
Diluted EPS (Rs.) | 11.01 | 10.84 | 11.36 | 6.24 | -1.59 |
Book Value /Share (Rs.) | 96.50 | 86.51 | 76.31 | 64.79 | 58.37 |
Dividend/Share (Rs.) | 1.50 | 1.50 | 0.00 | 0.00 | 0.00 |
Face Value | 10 | 10 | 10 | 10 | 10 |
Gross Profit Margin (%) | 28.51 | 30.89 | 30.24 | 27.21 | 20.70 |
Operating Margin (%) | 23.40 | 26.36 | 25.15 | 21.58 | 13.75 |
Net Profit Margin (%) | 15.30 | 19.56 | 24.18 | 15.38 | -4.57 |
Return on Networth / Equity (%) | 11.46 | 12.57 | 14.89 | 9.63 | -2.43 |
ROCE (%) | 12.27 | 13.25 | 12.67 | 10.06 | 4.43 |
Return On Assets (%) | 7.07 | 8.81 | 10.92 | 6.58 | -1.60 |
Current Ratio (X) | 0.88 | 1.37 | 1.86 | 1.32 | 1.45 |
Quick Ratio (X) | 0.82 | 1.30 | 1.79 | 1.24 | 1.38 |
Debt to Equity (x) | 0.27 | 0.14 | 0.08 | 0.12 | 0.16 |
Interest Coverage Ratios (X) | 12.15 | 27.89 | 16.45 | 10.61 | 1.92 |
Asset Turnover Ratio (%) | 0.52 | 0.49 | 0.22 | 0.22 | 29.31 |
Inventory Turnover Ratio (X) | 74.28 | 0.00 | 0.00 | 0.00 | 46.56 |
3 Yr CAGR Sales (%) | 33.71 | 46.91 | 107.56 | 6,170.14 | 4,904.67 |
3 Yr CAGR Net Profit (%) | 33.35 | 203.92 | 824.54 | 2,359.78 | 970.05 |
P/E (x) | 99.09 | 75.29 | 38.76 | 55.62 | -129.40 |
P/B (x) | 11.37 | 9.48 | 5.78 | 5.35 | 3.53 |
EV/EBITDA (x) | 54.09 | 47.77 | 30.38 | 31.65 | 38.85 |
P/S (x) | 15.17 | 14.75 | 9.38 | 8.56 | 7.95 |
The company announced a final dividend of Rs 1.50 per share (15%) on May 20, 2025, with an effective date of July 4, 2025. Additionally, the company allotted equity shares under the Employee Stock Option Scheme 2020.
Moneycontrol analysis on September 19, 2025, indicated very bearish sentiment for the stock.
Max Healthcare Institute Limited is a constituent of the Nifty Midcap 150 index. With the stock's last traded price at Rs 1,124.80, the stock is moved by -1.13% in today's session.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.